News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Gina Jamal, MD

Articles by Gina Jamal, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

New Phase 3 Data Analysis: Lumateperone Shows Promise for Remission of Major Depressive Disorder

First Patient Dose in Phase 3 Trial of AXS-14 for Treatment of Fibromyalgia

"The New Suicide Barrier"

Genetic Testing Could Be Helpful in Pediatric ADHD

Elevated Biomarkers of Alzheimer Disease Present in Patients with ADHD at Midlife: Poster Data From APSARD